SciVision Biotech Inc.

TWSE:1786 株式レポート

時価総額：NT$8.8b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

SciVision Biotech 将来の成長

Future 基準チェック /26

SciVision Biotechは収益が増加すると予測されています。

主要情報

n/a

収益成長率

n/a

EPS成長率

Medical Equipment 収益成長18.9%
収益成長率34.0%
将来の株主資本利益率n/a
アナリストカバレッジ

Low

最終更新日18 Jun 2024

今後の成長に関する最新情報

更新なし

Recent updates

SciVision Biotech Inc.'s (TWSE:1786) 27% Price Boost Is Out Of Tune With Earnings

Jun 14
SciVision Biotech Inc.'s (TWSE:1786) 27% Price Boost Is Out Of Tune With Earnings

SciVision Biotech (TWSE:1786) Seems To Use Debt Rather Sparingly

Jun 04
SciVision Biotech (TWSE:1786) Seems To Use Debt Rather Sparingly

Some Shareholders Feeling Restless Over SciVision Biotech Inc.'s (TWSE:1786) P/E Ratio

Apr 01
Some Shareholders Feeling Restless Over SciVision Biotech Inc.'s (TWSE:1786) P/E Ratio

Here's Why SciVision Biotech (TPE:1786) Can Manage Its Debt Responsibly

Apr 20
Here's Why SciVision Biotech (TPE:1786) Can Manage Its Debt Responsibly

SciVision Biotech (TPE:1786) Is Looking To Continue Growing Its Returns On Capital

Apr 02
SciVision Biotech (TPE:1786) Is Looking To Continue Growing Its Returns On Capital

Can You Imagine How SciVision Biotech's (TPE:1786) Shareholders Feel About The 33% Share Price Increase?

Mar 15
Can You Imagine How SciVision Biotech's (TPE:1786) Shareholders Feel About The 33% Share Price Increase?

Read This Before Buying SciVision Biotech Inc. (TPE:1786) For Its Dividend

Feb 25
Read This Before Buying SciVision Biotech Inc. (TPE:1786) For Its Dividend

Could The Market Be Wrong About SciVision Biotech Inc. (TPE:1786) Given Its Attractive Financial Prospects?

Feb 05
Could The Market Be Wrong About SciVision Biotech Inc. (TPE:1786) Given Its Attractive Financial Prospects?

Here's Why SciVision Biotech (TPE:1786) Can Manage Its Debt Responsibly

Jan 18
Here's Why SciVision Biotech (TPE:1786) Can Manage Its Debt Responsibly

Will The ROCE Trend At SciVision Biotech (TPE:1786) Continue?

Jan 01
Will The ROCE Trend At SciVision Biotech (TPE:1786) Continue?

SciVision Biotech (TPE:1786) Shareholders Booked A 80% Gain In The Last Three Years

Dec 14
SciVision Biotech (TPE:1786) Shareholders Booked A 80% Gain In The Last Three Years

Key Things To Consider Before Buying SciVision Biotech Inc. (TPE:1786) For Its Dividend

Nov 25
Key Things To Consider Before Buying SciVision Biotech Inc. (TPE:1786) For Its Dividend

業績と収益の成長予測

TWSE:1786 - アナリストの将来予測と過去の財務データ ( )TWD Millions
日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数
12/31/20251,431N/AN/A5551
12/31/20241,036N/AN/A4941
3/31/2024788197291305N/A
12/31/2023713178257272N/A
9/30/2023670168202223N/A
6/30/2023628159188209N/A
3/31/2023577148151169N/A
12/31/2022557142167182N/A
9/30/2022538138151162N/A
6/30/20225001128497N/A
3/31/2022495104116129N/A
12/31/20215061027399N/A
9/30/202149711298159N/A
6/30/202149112665129N/A
3/31/202146811658127N/A
12/31/202046712860126N/A
9/30/202046513383122N/A
6/30/202044712485189N/A
3/31/202044312730171N/A
12/31/20194381212204N/A
9/30/2019410112-109140N/A
6/30/2019380103-76120N/A
3/31/201933081-6099N/A
12/31/20183308716112N/A
9/30/201831473-8111N/A
6/30/201829658-49101N/A
3/31/201831455-46109N/A
12/31/201725817N/A16N/A
9/30/201724421N/A26N/A
6/30/2017251-28N/A-19N/A
3/31/2017231-28N/A-50N/A
12/31/2016228-26N/A38N/A
9/30/2016218-37N/A37N/A
6/30/201623836N/A95N/A
3/31/201625041N/A107N/A
12/31/201526555N/A50N/A
9/30/201523722N/A33N/A
6/30/2015197-5N/A11N/A
3/31/2015181-9N/A17N/A
12/31/2014158-22N/A2N/A
9/30/20141756N/A19N/A
6/30/201418826N/A2N/A
3/31/201419434N/A15N/A
12/31/201320140N/A37N/A
9/30/201322663N/A50N/A
6/30/201322565N/A58N/A

アナリストによる今後の成長予測

収入対貯蓄率: 1786の予測収益成長が 貯蓄率 ( 1% ) を上回っているかどうかを判断するにはデータが不十分です。

収益対市場: 1786の収益がTW市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です

高成長収益: 1786の収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。

収益対市場: 1786の収益 ( 35.6% ) TW市場 ( 11.3% ) よりも速いペースで成長すると予測されています。

高い収益成長: 1786の収益 ( 35.6% ) 20%よりも速いペースで成長すると予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: 1786の 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です

成長企業の発掘

7D

1Y

7D

1Y

7D

1Y